Cargando…

Epidemiological and clinical features of adult T‐cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey

Adult T‐cell leukemia–lymphoma (ATL) is a mature T‐cell malignancy associated with human T‐cell leukemia virus type 1 (HTLV‐1) infection. Japan is the most endemic country for HTLV‐1 and ATL in the world. Recent nationwide studies of Japanese blood donors reported that HTLV‐1 carriers spread from en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nosaka, Kisato, Iwanaga, Masako, Imaizumi, Yoshitaka, Ishitsuka, Kenji, Ishizawa, Kenichi, Ishida, Yoji, Amano, Masahiro, Ishida, Takashi, Uike, Naokuni, Utsunomiya, Atae, Ohshima, Koichi, Kawai, Kazuhiro, Tanaka, Junji, Tokura, Yoshiki, Tobinai, Kensei, Watanabe, Toshiki, Uchimaru, Kaoru, Tsukasaki, Kunihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715256/ https://www.ncbi.nlm.nih.gov/pubmed/28905463 http://dx.doi.org/10.1111/cas.13398

Ejemplares similares

Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study
por: Imaizumi, Yoshitaka, et al.
Publicado: (2020)

Epidemiology of adult T‐cell leukemia‐lymphoma in Japan: An updated analysis, 2012‐2013
por: Ito, Shigeki, et al.
Publicado: (2021)

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011)

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study
por: Ishida, Takashi, et al.
Publicado: (2015)

Overexpression of aberrant Wnt5a and its effect on acquisition of malignant phenotypes in adult T-cell leukemia/lymphoma (ATL) cells
por: Nakano, Kazumi, et al.
Publicado: (2021)

Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization
por: Farmanbar, Amir, et al.
Publicado: (2017)

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea
por: Ogura, Michinori, et al.
Publicado: (2020)

Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma
por: Ogura, Michinori, et al.
Publicado: (2016)

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
por: Uike, Naokuni, et al.
Publicado: (2011)

Clinical Trials and Treatment of ATL
por: Tsukasaki, Kunihiro, et al.
Publicado: (2012)

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
por: Izutsu, Koji, et al.
Publicado: (2023)

The kinetics of HTLV-1 proviral load after allogeneic hematopoietic cell transplantation with reduced intensity conditioning regimen; a comparison with that from sibling donors and that from unrelated donors
por: Choi, Ilseung, et al.
Publicado: (2014)

Disorders of the cMyb proto-oncogene expression and its significance in the course of ATL development
por: Nakano, Kazumi, et al.
Publicado: (2014)

The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma
por: Nakashima, Makoto, et al.
Publicado: (2023)

Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma
por: Ogura, Michinori, et al.
Publicado: (2014)

HTLV-1 modulates the frequency and phenotype of FoxP3(+)CD4(+) T cells in virus-infected individuals
por: Satou, Yorifumi, et al.
Publicado: (2012)

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
por: Cook, Lucy B., et al.
Publicado: (2019)

Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma
por: Cho, Ilseung, et al.
Publicado: (2015)

Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies
por: Ishida, Takashi, et al.
Publicado: (2017)

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation
por: Fuji, Shigeo, et al.
Publicado: (2017)

Genome wide association study of HTLV-1–associated myelopathy/tropical spastic paraparesis in the Japanese population
por: Penova, Marina, et al.
Publicado: (2021)

Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study
por: Iida, Shinsuke, et al.
Publicado: (2019)

R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
por: Ogura, Michinori, et al.
Publicado: (2018)

Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406
por: Ogura, Michinori, et al.
Publicado: (2023)

Functional impairment of Tax-specific but not CMV-specific CTLs in a minor population of asymptomatic HTLV-1-carriers
por: Hasegawa, Atsuhiko, et al.
Publicado: (2011)

Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma
por: Farmanbar, Amir, et al.
Publicado: (2018)

A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma
por: Watanabe, Takashi, et al.
Publicado: (2016)

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8(+ )T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers
por: Takamori, Ayako, et al.
Publicado: (2011)

Epigenetic deregulation of Ellis Van Creveld confers robust Hedgehog signaling in adult T-cell leukemia
por: Takahashi, Ryutaro, et al.
Publicado: (2014)

Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab
por: Nosaka, Kisato, et al.
Publicado: (2021)

Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
por: Tanaka, Norio, et al.
Publicado: (2022)

Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results
por: Utsunomiya, Atae, et al.
Publicado: (2022)

Genetic and epigenetic loss of miR-31 activates NIK-dependent NF-κB pathway in Adult T-cell Leukemia
por: Yamagishi, Makoto, et al.
Publicado: (2011)

Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia–lymphoma
por: Hiramatsu, Hiroaki, et al.
Publicado: (2022)

High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
por: Sasaki, Daisuke, et al.
Publicado: (2010)

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A
por: Kinoshita, Tomohiro, et al.
Publicado: (2021)

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges
por: Makita, Shinichi, et al.
Publicado: (2019)

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
por: Kagami, Yoshitoyo, et al.
Publicado: (2020)

Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan
por: Okuma, Kazu, et al.
Publicado: (2020)

Clinical landscape of TP73 structural variants in ATL patients
por: Hiramatsu, Hiroaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ih25to1en35o4s1o184uev7nk8